---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-031371"
form_type: "8-K"
ticker: "KNSA"
cik: "0001730430"
company_name: "Kiniksa Pharmaceuticals International, plc"
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:37:13.738504+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Kiniksa reveals no exposure to Silicon Valley Bank; no deposits or securities held

## Summary
- Kiniksa confirmed it did not hold cash deposits or securities with SVB.
- Company also stated it has no business relationship with SVB.
- Disclosure made on March 10, 2023, amid SVB liquidity crisis.
- This voluntary FD disclosure reassures investors of zero SVB exposure.

## SEC filing metadata
- accession: 0001104659-23-031371
- form_type: 8-K
- ticker: KNSA
- cik: 0001730430
- company_name: Kiniksa Pharmaceuticals International, plc
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1730430/000110465923031371/0001104659-23-031371-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1730430/000110465923031371/tm239243d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-031371
- JSON: https://secwatch.observer/filing/0001104659-23-031371.json
- Plain text: https://secwatch.observer/filing/0001104659-23-031371.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.